Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Concurrent Chemoradiation for Advanced NPC
NCT01712919Phase 2Completed
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- May 2010
- Primary completion
- Mar 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in nasopharyngeal carcinoma (NPC), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Started May 2010; status: completed.
02
Drugs
cetuximab
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01712919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712919.